Can you provide the average price target for VALVOLINE INC stock?
21 analysts have analysed VVV and the average price target is 42.62 USD. This implies a price increase of 23.31% is expected in the next year compared to the current price of 34.56.
NYSE:VVV • US92047W1018
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VALVOLINE INC (VVV).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-30 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2026-03-23 | Stifel | Upgrade | Hold -> Buy |
| 2026-02-12 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2026-02-06 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2026-02-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-05 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-18 | Roth Capital | Initiate | Buy |
| 2025-12-17 | Jefferies | Reiterate | Buy |
| 2025-12-15 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-20 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-20 | Stifel | Maintains | Hold -> Hold |
| 2025-11-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-20 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-20 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-20 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-11-20 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-20 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-10-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-29 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2030 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.444B 16.78% | 1.619B 12.16% | 1.71B 5.64% | 2.066B 20.80% | 2.283B 10.50% | 2.502B 9.59% | N/A | |
| EBITDA YoY % growth | 368.8M 21.68% | 472.4M 28.09% | 510.7M 8.11% | 549.18M 7.53% | 618.95M 12.70% | 684.2M 10.54% | N/A | |
| EBIT YoY % growth | 280M 20.85% | 366.5M 30.89% | 391.3M 6.77% | 402.6M 2.89% | 445.31M 10.61% | 494.42M 11.03% | 391.48M | |
| Operating Margin | 19.40% | 22.64% | 22.88% | 19.49% | 19.51% | 19.76% | N/A | |
| EPS YoY % growth | 1.21 -43.19% | 1.57 29.75% | 1.58 0.64% | 1.72 8.69% | 2.03 18.03% | 2.44 20.36% | N/A |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.35 1.49% | 0.50 7.19% | 0.49 9.75% | 0.41 10.24% | 0.43 24.64% | 0.62 22.30% | 0.60 21.34% | 0.51 23.81% |
| Revenue Q2Q % growth | 500.23M 24.06% | 541.61M 23.37% | 556.21M 22.57% | 539.71M 16.87% | 550.72M 10.09% | 597.99M 10.41% | 614.03M 10.40% | 626.91M 16.16% |
| EBITDA Q2Q % growth | 124.51M 0.33% | 153.28M -15.64% | 153.37M -24.71% | 136.99M 140.33% | 141.34M 13.52% | 173.76M 13.36% | 171.6M 11.89% | 152.31M 11.18% |
| EBIT Q2Q % growth | 87.11M 28.67% | 114.82M 20.74% | 113.05M 34.10% | 96.606M 311.09% | 100.19M 15.02% | 131.54M 14.56% | 127.66M 12.92% | 109.99M 13.85% |
All data in USD
21 analysts have analysed VVV and the average price target is 42.62 USD. This implies a price increase of 23.31% is expected in the next year compared to the current price of 34.56.
VALVOLINE INC (VVV) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of VALVOLINE INC (VVV) is 0.35 USD and the consensus revenue estimate is 500.23M USD.
The expected long term growth rate for VALVOLINE INC (VVV) is 13.13%.